NCT07613541Not yet recruiting
Translation and Cultural Adaptation of the Erasmus Modified Nottingham Sensory Assessment Scale for the Lower Limb in Acquired Brain Injury Into French
Source: ClinicalTrials.gov · Last updated 29 May 2026
Brief summary (registry, in English)
There is a lack of validated and standardized tools in French for assessing somatosensory perception in adults with brain injuries. The only validated tool in French is the Fugl-Meyer Scale for Sensorimotor Recovery after a Stroke, which assesses only light touch sensitivity in two areas of the arm and leg, as well as proprioception for eight joints. The Erasmus Modified Nottingham Sensory Assessment (EmNSA) offers a detailed assessment of limb somatosensory perception in English. The upper limb (UL) version has been validated in French. The lower limb component remains to be translated and culturally adapted. This cross-cultural translation and adaptation project aims to validate this tool for a comprehensive clinical assessment of somatosensory deficits, applicable in both clinical practice and research. The project aims to validate the study of the metrological qualities (validity and reliability of the scale) of the French version of the EmNSA for the lower limbs.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 21 May 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Stroke
- NCT number
- NCT07613541
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Jun 2026 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe communication disorders with a score of less than 4 on the Aphasia Severity Scale
- Major attention disorders making it impossible to take stock
Other
- Patient with peripheral neurological pathology
- Anosognosia Assessment (from the Unilateral Neglect Assessment Battery) score of 2 or higher
- Patient under guardianship
Who the study is looking for
- Patient with an acquired brain injury attested by brain imaging (CT scan or MRI) of more than seven days
- Sufficient comprehension ability to participate in the study
- Patients receiving care in the routine care pathway, as part of rehabilitation or functional assessments available for 6 weeks minimum and 12 weeks maximum
- Ability to hold attention for at least 30 minutes
- Aphasia Severity Scale score of 4 or higher
- Anosognosia Assessment (from the Unilateral Neglect Assessment Battery) score of 1 or lower
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service des Explorations Fonctionnelles Physiologiques (Pôle 32) - Hôpital Purpan, Place du Dr Baylac Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.